RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
RARX
Delisted
RARX was delisted on the 1st of April, 2020.
62 hedge funds and large institutions have $233M invested in Ra Pharmaceuticals, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
62
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$7.72M | |
| 2 | +$3.84M | |
| 3 | +$1.49M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$807K |
| 5 |
Goldman Sachs
New York
|
+$596K |
Top Sellers
| 1 | -$4.2M | |
| 2 | -$2.39M | |
| 3 | -$1.73M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1.56M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$1.43M |